A novel gene therapy for Huntington’s Disease that leverage zinc finger protein technology.
Technology Sectors & Industries
Biotechnology
Filter
Catch up: Affordable technologies for an ageing society
Imperial.Tech.Pitch: Affordable technologies for an ageing society centred on the premise that within 20 years, there will be 25% fewer taxpayers to pensioners in the UK than in 2020.
Professor Molly Stevens
Imperial.tech.pitch events – learn more and sign up
Learn about our programme of events and sign up to be alerted for future events
MyoLoop for cardiovascular research
MyoLoop is a device that can simulate pathological conditions (e.g. hypertension), to study their progression, and the effects of therapeutic interventions on them.
Professor Cesare Terracciano
Professor Joshua B. Edel
MicroRNA Biomarkers for ectopic or intrauterine pregnancy
MicroRNA are important gene regulators and their expression profiles change with pathophysiology, allowing their use as biomarkers. Imperial researchers have identified differential markers that can distinguish pregnancy of unknown location (PUL).
Zinc finger therapy for Amyotrophic lateral sclerosis (ALS) and Frontotemporal dementia (FTD)
A zinc finger to target both the ALS and FTD therapeutically
Zinc finger therapy for Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS)
A zinc finger (zf) to target the FXTAS mutation therapeutically
Sign up for updates
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean nec venenatis arcu. In fermentum non tellus nec vulputate. Integer accumsan, nunc sit amet porta commodo, diam sapien feugiat purus, at imperdiet arcu nisi quis dui. Etiam vel nisl sem. Proin felis nisl, fringilla eu eros ac, sodales pellentesque sem.